-
1دورية أكاديمية
المؤلفون: Eichhorst, Barbara, Niemann, Carsten U., Kater, Arnon P., Furstenau, Moritz, Von Tresckow, Julia, Zhang, Can, Robrecht, Sandra, Gregor, Michael, Juliusson, Gunnar, Thornton, Patrick, Staber, Philipp B., Tadmor, Tamar, Lindstrom, Vesa, Da Cunha-Bang, Caspar, Schneider, Christof, Poulsen, Christian B., Illmer, Thomas, Schottker, Bjorn, Nosslinger, Thomas, Janssens, Ann, Christiansen, Ilse, Baumann, Michael, Frederiksen, Henrik, Van Der Klift, Marjolein, Jager, Ulrich, Leys, Maria B.L., Hoogendoorn, Mels, Lotfi, Kourosh, Hebart, Holger, Gaska, Tobias, Koene, Harry, Enggaard, Lisbeth, Goede, Jereon, Regelink, Josien C., Widmer, Anouk, Simon, Florian, De Silva, Nisha, Fink, Anna Maria, Bahlo, Jasmin, Fischer, Kirsten, Wendtner, Clemens Martin, Kreuzer, Karl A., Ritgen, Matthias, Bruggemann, Monika, Tausch, Eugen, Levin, Mark David, Van Oers, Marinus, Geisler, Christian, Stilgenbauer, Stephan, Hallek, Michael
المصدر: Eichhorst , B , Niemann , C U , Kater , A P , Furstenau , M , Von Tresckow , J , Zhang , C , Robrecht , S , Gregor , M , Juliusson , G , Thornton , P , Staber , P B , Tadmor , T , Lindstrom , V , Da Cunha-Bang , C , Schneider , C , Poulsen , C B , Illmer , T , Schottker , B , Nosslinger , T , Janssens , A , Christiansen , I , Baumann , M , Frederiksen , H , Van ....
مصطلحات موضوعية: Hematology/Oncology, Leukemia/Lymphoma, Treatments in Oncology, Antineoplastic Agents/administration & dosage, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Antineoplastic Agents, Immunological/administration & dosage, Rituximab/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Bridged Bicyclo Compounds, Heterocyclic/administration & dosage, Cyclophosphamide/administration & dosage, Neoplasm, Residual/diagnosis, Bendamustine Hydrochloride/administration & dosage
وصف الملف: application/pdf
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/40d039f1-27c3-4be2-b60a-e04115b02874Test
الإتاحة: https://doi.org/10.1056/NEJMoa2213093Test
https://portal.findresearcher.sdu.dk/da/publications/40d039f1-27c3-4be2-b60a-e04115b02874Test
https://findresearcher.sdu.dk/ws/files/253573429/00006024-202305110-00004.pdfTest -
2دورية أكاديمية
المساهمون: Eric Van Cutsem, Mayur Amonkar, Charles S Fuchs, Maria Alsina, Mustafa Özgüroğlu, Yung-Jue Bang, Hyun Cheol Chung, Kei Muro, Eray Goekkurt, Al B Benson 3rd, Weijing Sun, Zev A Wainberg, Josephine M Norquist, Xinqun Chen, Chie-Schin Shih, Kohei Shitara, Chung, Hyun Cheol
مصطلحات موضوعية: Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / therapeutic use, Antineoplastic Agents, Immunological / administration & dosage, Immunological / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Belgium, Esophagogastric Junction, Humans, Neoplasm Metastasis, Progression-Free Survival, Quality of Life, Stomach Neoplasms / drug therapy, Stomach Neoplasms / mortality, Stomach Neoplasms / pathology, Surveys and Questionnaires, Chemotherapy, Gastric cancer, HRQoL, Pembrolizumab
العلاقة: GASTRIC CANCER; J00916; OAK-2022-04767; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190695Test; T9992022100; GASTRIC CANCER, Vol.24(6) : 1330-1340, 2021-11
الإتاحة: https://doi.org/10.1007/s10120-021-01200-wTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190695Test -
3دورية أكاديمية
المساهمون: Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K Sabari, Alexander I Spira, Tsung-Ying Yang, Dong-Wan Kim, Ki Hyeong Lee, Rachel E Sanborn, José Trigo, Koichi Goto, Jong-Seok Lee, James Chih-Hsin Yang, Ramaswamy Govindan, Joshua M Bauml, Pilar Garrido, Matthew G Krebs, Karen L Reckamp, John Xie, Joshua C Curtin, Nahor Haddish-Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E Knoblauch, Byoung Chul Cho, Cho, Byoung Chul
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Bispecific / administration & dosage, Bispecific / adverse effects, Bispecific / pharmacokinetics, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, Immunological / pharmacokinetics, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / genetics, Non-Small-Cell Lung / secondary, Diarrhea / chemically induced, Disease Progression, Drug Eruptions / etiology, ErbB Receptors / genetics, Exons, Female, Humans, Hypokalemia / chemically induced, Injection Site Reaction / etiology, Lung Neoplasms / drug therapy, Lung Neoplasms / genetics, Lung Neoplasms / pathology, Male, Middle Aged, Mutagenesis
العلاقة: JOURNAL OF CLINICAL ONCOLOGY; J01331; OAK-2021-10033; https://ir.ymlib.yonsei.ac.kr/handle/22282913/187654Test; T202125019; JOURNAL OF CLINICAL ONCOLOGY, Vol.39(30) : 3391-3402, 2021-10
الإتاحة: https://doi.org/10.1200/JCO.21.00662Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/187654Test -
4
المؤلفون: Barbara Eichhorst, Carsten U. Niemann, Arnon P. Kater, Moritz Fürstenau, Julia von Tresckow, Can Zhang, Sandra Robrecht, Michael Gregor, Gunnar Juliusson, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Vesa Lindström, Caspar da Cunha-Bang, Christof Schneider, Christian B. Poulsen, Thomas Illmer, Björn Schöttker, Thomas Nösslinger, Ann Janssens, Ilse Christiansen, Michael Baumann, Henrik Frederiksen, Marjolein van der Klift, Ulrich Jäger, Maria B.L. Leys, Mels Hoogendoorn, Kourosh Lotfi, Holger Hebart, Tobias Gaska, Harry Koene, Lisbeth Enggaard, Jereon Goede, Josien C. Regelink, Anouk Widmer, Florian Simon, Nisha De Silva, Anna-Maria Fink, Jasmin Bahlo, Kirsten Fischer, Clemens-Martin Wendtner, Karl A. Kreuzer, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Mark-David Levin, Marinus van Oers, Christian Geisler, Stephan Stilgenbauer, Michael Hallek
المصدر: Eichhorst, B, Niemann, C U, Kater, A P, Fürstenau, M, von Tresckow, J, Zhang, C, Robrecht, S, Gregor, M, Juliusson, G, Thornton, P, Staber, P B, Tadmor, T, Lindström, V, da Cunha-Bang, C, Schneider, C, Poulsen, C B, Illmer, T, Schöttker, B, Nösslinger, T, Janssens, A, Christiansen, I, Baumann, M, Frederiksen, H, van der Klift, M, Jäger, U, Leys, M B L, Hoogendoorn, M, Lotfi, K, Hebart, H, Gaska, T, Koene, H, Enggaard, L, Goede, J, Regelink, J C, Widmer, A, Simon, F, De Silva, N, Fink, A-M, Bahlo, J, Fischer, K, Wendtner, C-M, Kreuzer, K A, Ritgen, M, Brüggemann, M, Tausch, E, Levin, M-D, van Oers, M, Geisler, C, Stilgenbauer, S, Hallek, M, German CLL Study Group (GCLLSG), Haemato-Oncology Foundation for Adults in the Netherlands (HOVON), Nordic CLL Study Groups, Swiss Group for Clinical Cancer Research (SAKK), The Israeli CLL Association & Cancer Trials Ireland 2023, ' First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia ', The New England Journal of Medicine, vol. 388, no. 19, pp. 1739-1754 . https://doi.org/10.1056/NEJMoa2213093Test
مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoplasm, Residual/diagnosis, General Medicine, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Hematology/Oncology, Antineoplastic Agents/administration & dosage, Cyclophosphamide/administration & dosage, Rituximab/administration & dosage, Bridged Bicyclo Compounds, Heterocyclic/administration & dosage, Antineoplastic Agents, Immunological/administration & dosage, Leukemia/Lymphoma, Humans, Bendamustine Hydrochloride/administration & dosage, Treatments in Oncology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57065540dd32adf0cc1d031449d13807Test
https://vbn.aau.dk/da/publications/3cae35e7-c81b-42b3-8598-001ac74af83eTest -
5دورية أكاديمية
المساهمون: Hope S Rugo, Aditya Bardia, Sara M Tolaney, Carlos Arteaga, Javier Cortes, Joohyuk Sohn, Frederik Marmé, Quan Hong, Rosemary J Delaney, Amir Hafeez, Fabrice André, Peter Schmid, Sohn, Joo Hyuk
مصطلحات موضوعية: Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / adverse effects, Humanized / therapeutic use, Antigens, Neoplasm, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, Immunological / therapeutic use, Biomarkers, Tumor, Breast Neoplasms / drug therapy, Breast Neoplasms / etiology, Breast Neoplasms / metabolism, Breast Neoplasms / pathology, Camptothecin / administration & dosage, Camptothecin / adverse effects, Camptothecin / analogs & derivatives, Camptothecin / therapeutic use, Cell Adhesion Molecules / antagonists & inhibitors, Drug Resistance, Female, Humans, Immunoconjugates / administration & dosage, Immunoconjugates / adverse effects, Immunoconjugates / therapeutic use, Molecular Targeted Therapy, Neoplasm Metastasis
العلاقة: FUTURE ONCOLOGY; J00914; OAK-2021-05739; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185005Test; T999202314; FUTURE ONCOLOGY, Vol.16(12) : 705-715, 2020-04
الإتاحة: https://doi.org/10.2217/fon-2020-0163Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/185005Test -
6دورية أكاديمية
المساهمون: Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda, Choi, Hye Jin
مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, B7-H1 Antigen / antagonists & inhibitors, B7-H1 Antigen / immunology, Biliary Tract Neoplasms / drug therapy, Biliary Tract Neoplasms / immunology, Biliary Tract Neoplasms / mortality, Female, Humans, Immunoconjugates / administration & dosage, Immunoconjugates / adverse effects, Immunoconjugates / genetics, Male, Middle Aged, Progression-Free Survival, Receptor, Transforming Growth Factor-beta Type II / genetics, Recombinant Fusion Proteins / administration & dosage, Recombinant Fusion Proteins / adverse effects, Recombinant Fusion Proteins / genetics, Signal Transduction / drug effects, Signal Transduction / immunology, Transforming Growth Factor beta / antagonists & inhibitors, Transforming Growth Factor beta / metabolism, Young Adult, gastrointestinal neoplasms, immunotherapy
العلاقة: JOURNAL FOR IMMUNOTHERAPY OF CANCER; J03617; OAK-2021-02662; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183954Test; T202007285; JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol.8(1) : e000564, 2020-05
الإتاحة: https://doi.org/10.1136/jitc-2020-000564Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/183954Test -
7دورية أكاديمية
المساهمون: Aurélien Marabelle, Marwan Fakih, Juanita Lopez, Manisha Shah 4, Ronnie Shapira-Frommer 5, Kazuhiko Nakagawa 6, Hyun Cheol Chung 7, Hedy L Kindler 8, Jose A Lopez-Martin 9, Wilson H Miller Jr 10, Antoine Italiano 11, Steven Kao 12, Sarina A Piha-Paul 13, Jean-Pierre Delord 14, Robert R McWilliams 15, David A Fabrizio 16, Deepti Aurora-Garg 17, Lei Xu 17, Fan Jin 17, Kevin Norwood 17, Yung-Jue Bang 18, Chung, Hyun Cheol
مصطلحات موضوعية: Aged, Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, Biomarkers, Tumor / genetics, Tumor / metabolism, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Immunotherapy, Male, Middle Aged, Mutation, Neoplasms / genetics, Neoplasms / pathology, Neoplasms / therapy, Prospective Studies, Response Evaluation Criteria in Solid Tumors, Survival Analysis
العلاقة: LANCET ONCOLOGY; J02154; OAK-2021-02519; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183868Test; https://www.sciencedirect.com/science/article/pii/S1470204520304459Test; T202007183; LANCET ONCOLOGY, Vol.21(10) : 1353-1365, 2020-10
الإتاحة: https://doi.org/10.1016/S1470-2045Test(20)30445-9
https://ir.ymlib.yonsei.ac.kr/handle/22282913/183868Test
https://www.sciencedirect.com/science/article/pii/S1470204520304459Test -
8دورية أكاديمية
المساهمون: Beung-Chul Ahn, Kyoung-Ho Pyo, Chun-Feng Xin, Dongmin Jung, Hyo Sup Shim, Chang Young Lee, Seong Yong Park, Hong In Yoon, Min Hee Hong, Byoung Chul Cho, Hye Ryun Kim, Kim, Hye Ryun
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized/administration & dosage, Antineoplastic Agents, Immunological/administration & dosage, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/immunology, Non-Small-Cell Lung/pathology, Female, Humans, Lung Neoplasms/drug therapy, Lung Neoplasms/immunology, Lung Neoplasms/pathology, Male, Middle Aged, Nivolumab/administration & dosage, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Programmed Cell Death 1 Receptor/immunology, Retrospective Studies, Treatment Outcome, Immunotherapy, Non-smallcelllungcancer, PD-1, Real-worldsetting, Survival
العلاقة: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; J01283; OAK-2019-02242; https://ir.ymlib.yonsei.ac.kr/handle/22282913/170301Test; T201902062; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, Vol.145(6) : 1613-1623, 2019; 61927
الإتاحة: https://doi.org/10.1007/s00432-019-02899-yTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/170301Test -
9دورية أكاديمية
المؤلفون: Pillonel, V., Dunet, V., Hottinger, A.F., Berthod, G., Schiappacasse, L., Peters, S., Michielin, O., Aedo-Lopez, V.
المصدر: Journal for immunotherapy of cancer, vol. 7, no. 1, pp. 336
مصطلحات موضوعية: Adult, Antineoplastic Agents, Immunological/administration & dosage, Immunological/adverse effects, Asymptomatic Diseases, Demyelinating Diseases/diagnosis, Demyelinating Diseases/etiology, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Melanoma/complications, Melanoma/diagnosis, Melanoma/drug therapy, Nivolumab/administration & dosage, Nivolumab/adverse effects, Remission, Spontaneous, CNS demyelination, Immune checkpoint inhibitors, Immune related adverse events, Metastatic melanoma, Neurological toxicities, Nivolumab
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31791418; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_9C48A9CE403D3; https://serval.unil.ch/notice/serval:BIB_9C48A9CE403DTest; urn:issn:2051-1426; https://serval.unil.ch/resource/serval:BIB_9C48A9CE403D.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_9C48A9CE403D3Test
الإتاحة: https://doi.org/10.1186/s40425-019-0818-3Test
https://serval.unil.ch/notice/serval:BIB_9C48A9CE403DTest
https://serval.unil.ch/resource/serval:BIB_9C48A9CE403D.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_9C48A9CE403D3Test -
10دورية أكاديمية
المؤلفون: Zezza, M., Kosinski, C., Mekoguem, C., Marino, L., Chtioui, H., Pitteloud, N., Lamine, F.
المصدر: BMC endocrine disorders, vol. 19, no. 1, pp. 144
مصطلحات موضوعية: Acute Disease, Aged, 80 and over, Antineoplastic Agents, Immunological/administration & dosage, Immunological/adverse effects, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Diabetes Mellitus, Type 1/chemically induced, Type 1/diagnosis, Type 1/pathology, Female, Humans, Ipilimumab/administration & dosage, Ipilimumab/adverse effects, Male, Melanoma/drug therapy, Melanoma/pathology, Middle Aged, Nivolumab/administration & dosage, Nivolumab/adverse effects, Skin Neoplasms/drug therapy, Skin Neoplasms/pathology, Autoimmune adverse events, Endocrinopathies, Immune checkpoint inhibitor, Type 1 diabetes
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31870373; info:eu-repo/semantics/altIdentifier/eissn/1472-6823; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_CB7AD473C23D2; https://serval.unil.ch/notice/serval:BIB_CB7AD473C23DTest; urn:issn:1472-6823; https://serval.unil.ch/resource/serval:BIB_CB7AD473C23D.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_CB7AD473C23D2Test
الإتاحة: https://doi.org/10.1186/s12902-019-0467-zTest
https://serval.unil.ch/notice/serval:BIB_CB7AD473C23DTest
https://serval.unil.ch/resource/serval:BIB_CB7AD473C23D.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_CB7AD473C23D2Test